Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
about
EMT-Inducing Molecular Factors in Gynecological CancersS100 expression in dendritic cells is inversely correlated with tumor grade in endometrial carcinoma.Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma.Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.WNT signaling suppression in the senescent human thymus.Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.The EMT signaling pathways in endometrial carcinoma.The migratory capacity of human trophoblastic BeWo cells: effects of aldosterone and the epithelial sodium channel.Progesterone prevents epithelial-mesenchymal transition of ovine amniotic epithelial cells and enhances their immunomodulatory properties.In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.Expression and significance of biglycan in endometrial cancer.Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway.Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.A mouse model for endometrioid ovarian cancer arising from the distal oviduct.
P2860
Q26781912-15064CD9-EA93-4ACF-B97F-77EA3D074132Q33686479-10267A50-B486-4494-9BED-F8929FC469F3Q33872622-BD35E746-2196-4EA9-92D2-1C7C7202ACEBQ34011765-631545ED-23DB-4E17-97B9-2083C6D7181BQ34388048-558A8E64-DE2E-435B-9F9A-4E197CA40E87Q34807396-493C7EE3-98E7-4A08-934C-50900D87DB98Q35152869-C4FAF376-9055-4DC3-8A96-FAE466428722Q36908874-D42B1FDB-242D-47C3-B645-2AF13906BD6EQ38036605-0A50FD7C-B4C4-49A4-BDB7-22FF5FE1CB77Q39203698-5A379B6F-BAF1-4569-A0B4-C8E296C9C01AQ41095448-6B1E3718-8EC4-40ED-9EF7-206187A32866Q42645301-4C7D6F1D-B75B-444D-88AE-A1891CB0872EQ45391946-7884CD08-7ECF-47D8-BCFA-F3BC8A852F0FQ47134679-DB09BC83-4119-4A28-8AAB-6799A76F9342Q53121562-66425873-5993-42F2-AF52-B0ECE7D11832Q54296090-149D6DA9-CDFF-498D-BC8A-BE4D6E6A914D
P2860
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@ast
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@en
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@nl
type
label
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@ast
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@en
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@nl
prefLabel
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@ast
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@en
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@nl
P2093
P2860
P1433
P1476
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
@en
P2093
Curt W Burger
Frederic Amant
Ingrid Vandenput
Leen J Blok
Liesbeth C Kühne
Marten van der Zee
Patricia C Ewing
Paul H van der Horst
Yongyi Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0030840
P407
P577
2012-01-25T00:00:00Z